Daniel G Maluf
Overview
Explore the profile of Daniel G Maluf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McDaniels J, Shetty A, Rousselle T, Bardhi E, Maluf D, Mas V
Front Transplant
. 2024 Jul;
1:988238.
PMID: 38994377
Despite recent advances made in short-term outcomes; minimal improvements have been observed in long-term kidney transplantation outcomes. Due to an imbalance between organ transplant availability and patient waiting list, expanding...
2.
Rousselle T, McDaniels J, Shetty A, Bardhi E, Maluf D, Mas V
Sci Rep
. 2024 Jul;
14(1):15385.
PMID: 38965279
No abstract available.
3.
Meier R, Kamberi S, Alvarez-Casas J, Lane B, Bhati C, Malik S, et al.
Prog Transplant
. 2023 Nov;
:15269248231212914.
PMID: 37941349
No abstract available.
4.
Berenguer M, De Martin E, Hessheimer A, Levitsky J, Maluf D, Mas V, et al.
Transpl Int
. 2023 Sep;
36:11358.
PMID: 37711401
Currently, one-year survival following liver transplantation (LT) exceeds 90% in large international registries, and LT is considered definitive treatment for patients with end-stage liver disease and liver cancer. Recurrence of...
5.
Azim S, Zubair H, Rousselle T, McDaniels J, Shetty A, Kuscu C, et al.
Am J Transplant
. 2023 May;
23(9):1434-1445.
PMID: 37201755
Operational tolerance (OT) after kidney transplantation is defined as stable graft acceptance without the need for immunosuppression therapy. However, it is not clear which cellular and molecular pathways are driving...
6.
McDaniels J, Shetty A, Kuscu C, Kuscu C, Bardhi E, Rousselle T, et al.
Kidney Int
. 2023 Mar;
103(6):1077-1092.
PMID: 36863444
Chronic allograft dysfunction (CAD), characterized histologically by interstitial fibrosis and tubular atrophy, is the major cause of kidney allograft loss. Here, using single nuclei RNA sequencing and transcriptome analysis, we...
7.
Zubair H, Azim S, Maluf D, Mas V, Martins P
Transplantation
. 2023 Feb;
107(10):2143-2154.
PMID: 36814094
Solid organ transplantation saves thousands of lives suffering from end-stage diseases. Although early transplants experienced acute organ injury, medical breakthroughs, such as tissue typing, and use of immunosuppressive agents have...
8.
McDaniels J, Maluf D, Mas V
Transplantation
. 2022 Oct;
107(4):822-823.
PMID: 36289557
No abstract available.
9.
Carrier A, Verma A, Mohiuddin M, Pascual M, Muller Y, Longchamp A, et al.
Front Immunol
. 2022 Jun;
13:900594.
PMID: 35757701
Organ allotransplantation has now reached an impassable ceiling inherent to the limited supply of human donor organs. In the United States, there are currently over 100,000 individuals on the national...
10.
Archer K, Bardhi E, Maluf D, McDaniels J, Rousselle T, King A, et al.
Am J Transplant
. 2022 Jun;
22(11):2515-2528.
PMID: 35730259
With the development of novel prognostic tools derived from omics technologies, transplant medicine is entering the era of precision medicine. Currently, there are no established predictive biomarkers for posttransplant kidney...